DE3668792D1 - Mikrokapseln. - Google Patents

Mikrokapseln.

Info

Publication number
DE3668792D1
DE3668792D1 DE8686850334T DE3668792T DE3668792D1 DE 3668792 D1 DE3668792 D1 DE 3668792D1 DE 8686850334 T DE8686850334 T DE 8686850334T DE 3668792 T DE3668792 T DE 3668792T DE 3668792 D1 DE3668792 D1 DE 3668792D1
Authority
DE
Germany
Prior art keywords
capsules
micro
polar
hydrophobic
relates
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE8686850334T
Other languages
English (en)
Inventor
Bo Magnus Ekman
Kare Viktor Larsson
Aeke Rikard Lindahl
Ulf Sven Erik Rothman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Jagotec AG
Original Assignee
Biogram AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biogram AB filed Critical Biogram AB
Application granted granted Critical
Publication of DE3668792D1 publication Critical patent/DE3668792D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/11—Encapsulated compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A61K8/347—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37—Esters of carboxylic acids
    • A61K8/375—Esters of carboxylic acids the alcohol moiety containing more than one hydroxy group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers with substantial amounts of non-phosphatidyl, i.e. non-acylglycerophosphate, surfactants as bilayer-forming substances, e.g. cationic lipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1274—Non-vesicle bilayer structures, e.g. liquid crystals, tubules, cubic phases, cochleates; Sponge phases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J13/00—Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for; Making microcapsules or microballoons
    • B01J13/02—Making microcapsules or microballoons
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J13/00—Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for; Making microcapsules or microballoons
    • B01J13/02—Making microcapsules or microballoons
    • B01J13/06—Making microcapsules or microballoons by phase separation
    • B01J13/08—Simple coacervation, i.e. addition of highly hydrophilic material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/41—Particular ingredients further characterized by their size
    • A61K2800/412—Microsized, i.e. having sizes between 0.1 and 100 microns
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
    • Y10T428/2984—Microcapsule with fluid core [includes liposome]
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
    • Y10T428/2989—Microcapsule with solid core [includes liposome]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Birds (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Emergency Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Cosmetics (AREA)
  • Developing Agents For Electrophotography (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DE8686850334T 1985-10-28 1986-10-06 Mikrokapseln. Expired - Lifetime DE3668792D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8505086A SE462894B (sv) 1985-10-28 1985-10-28 Mikrokapslar, foerfarande foer framstaellning daerav samt anvaendning

Publications (1)

Publication Number Publication Date
DE3668792D1 true DE3668792D1 (de) 1990-03-15

Family

ID=20361951

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8686850334T Expired - Lifetime DE3668792D1 (de) 1985-10-28 1986-10-06 Mikrokapseln.

Country Status (19)

Country Link
US (1) US4931284A (de)
EP (1) EP0224457B1 (de)
JP (1) JPS63501150A (de)
KR (1) KR940000230B1 (de)
AT (1) ATE50158T1 (de)
AU (1) AU586513B2 (de)
CA (1) CA1286928C (de)
DE (1) DE3668792D1 (de)
DK (1) DK175157B1 (de)
ES (1) ES2013724B3 (de)
FI (1) FI92647C (de)
GR (1) GR3000410T3 (de)
IL (1) IL80125A (de)
IN (1) IN165089B (de)
NZ (1) NZ217929A (de)
PH (1) PH21729A (de)
SE (1) SE462894B (de)
WO (1) WO1987002582A1 (de)
ZA (1) ZA867288B (de)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2620028B2 (fr) * 1986-12-05 1994-02-25 Ire Celltarg Sa Procede de preparation de microcristaux comportant a titre de substance active, notamment de l'amphotericine b, microcristaux obtenus et composition pharmaceutique en comprenant
CA1338736C (fr) * 1986-12-05 1996-11-26 Roger Baurain Microcristaux comportant une substance active presentant une affinite pour les phospholipides, et au moins un phospholipide, procede de preparation
FR2628317B1 (fr) * 1988-03-09 1991-11-08 Lvmh Rech Composition a base de phases lamellaires lipidiques hydratees ou de liposomes contenant un extrait de scutellaria, ou au moins un flavonoide tel que baicaleine ou baicaline et composition cosmetique ou pharmaceutique, notamment dermatologique, a activite anti-allergique, anti-inflammatoire ou anti-vieillissement, l'incorporant
US5174988A (en) * 1989-07-27 1992-12-29 Scientific Development & Research, Inc. Phospholipid delivery system
US5213810A (en) * 1990-03-30 1993-05-25 American Cyanamid Company Stable compositions for parenteral administration and method of making same
FR2660554B1 (fr) * 1990-04-05 1992-07-03 Oreal Composition cosmetique ou dermo-pharmaceutique aqueuse contenant en suspension des spherouides hydrates d'une substance lipidique hydrophile.
GB9021061D0 (en) * 1990-09-27 1990-11-07 Unilever Plc Encapsulating method and products containing encapsulated material
ES2056665T5 (es) * 1990-11-23 1998-05-01 Unilever Nv Uso de fases mesomorficas en productos alimentarios.
CA2089494C (en) * 1991-06-26 2005-09-20 Tom De Vringer Vesicles in non-polar media
FR2681247B1 (fr) * 1991-09-17 1993-12-03 Oreal Composition pharmaceutique pour application topique contenant du dithranol et procede de preparation.
CA2082561A1 (en) * 1991-11-12 1993-05-13 Francis J. Leng Antiperspirant materials and compositions
US6368653B1 (en) 1992-03-05 2002-04-09 Van Den Berghfoods Co., Division Of Conopco, Inc. Use of mesomorphic phases in food products
US5620734A (en) * 1992-03-05 1997-04-15 Van Den Bergh Foods Co., Division Of Conopco, Inc. Spreads and other products including mesomorphic phases
US5785976A (en) * 1993-03-05 1998-07-28 Pharmacia & Upjohn Ab Solid lipid particles, particles of bioactive agents and methods for the manufacture and use thereof
US5885486A (en) * 1993-03-05 1999-03-23 Pharmaciaand Upjohn Ab Solid lipid particles, particles of bioactive agents and methods for the manufacture and use thereof
US5578709A (en) * 1993-03-09 1996-11-26 Middlesex Sciences, Inc. Macromolecular microparticles and methods of production
US6090925A (en) 1993-03-09 2000-07-18 Epic Therapeutics, Inc. Macromolecular microparticles and methods of production and use
US20050181976A1 (en) * 1993-05-10 2005-08-18 Ekwuribe Nnochiri N. Amphiphilic oligomers
FR2715069B1 (fr) * 1994-01-20 1996-04-05 Rene Laversanne Procédé pour améliorer la rémanence d'une odeur.
DE4414755C2 (de) * 1994-04-27 2000-11-16 Lohmann Therapie Syst Lts Kollagenzubereitung zur gesteuerten Abgabe von Wirkstoffen, Verfahren und Verwendung
CN1138591C (zh) 1997-09-09 2004-02-18 莱奥特罗皮克治疗公司 包覆颗粒以及其制备和使用方法
US6638621B2 (en) * 2000-08-16 2003-10-28 Lyotropic Therapeutics, Inc. Coated particles, methods of making and using
DE19748796A1 (de) * 1997-11-05 1999-05-06 Beiersdorf Ag Verfahren zur Herstellung von Liposomen
US6262152B1 (en) 1998-10-06 2001-07-17 E. I. Du Pont De Nemours And Company Particles dispersed w/polymer dispersant having liquid soluble and cross-linkable insoluble segments
US6676930B2 (en) * 1999-11-28 2004-01-13 Scientific Development And Research, Inc. Composition and method for treatment of otitis media
US6156294A (en) * 1999-11-28 2000-12-05 Scientific Development And Research, Inc. Composition and method for treatment of otitis media
US20020153508A1 (en) * 2000-06-29 2002-10-24 Lynch Matthew Lawrence Cubic liquid crystalline compositions and methods for their preparation
KR100489318B1 (ko) * 2001-08-25 2005-05-17 이원목 비타민 마이크로캡슐을 포함하는 섬유 유연제 조성물
US6808715B2 (en) 2001-11-09 2004-10-26 Or-Le-Or Ltd. Wrinkle cream
DK1448186T3 (da) 2001-11-19 2009-04-14 Medigene Ag Lægemiddel til behandling af virale hud- og tumorsygdomme
DE10156794B4 (de) * 2001-11-19 2006-05-18 Medigene Ag Arzneimittel zur Behandlung von Warzen
US20030232091A1 (en) * 2002-06-17 2003-12-18 Adi Shefer Stabilized retinol for cosmetic dermatological, and pharmaceutical compositions, and use thereof
AU2002356294A1 (en) 2002-12-13 2004-07-09 Jagotec Ag A topical nanoparticulate spironolactone formulation
US7910138B2 (en) 2003-10-09 2011-03-22 Medigene Ag Use of a polyphenol for the treatment of a cancerous or precancerous lesion of the skin
US20050079235A1 (en) * 2003-10-09 2005-04-14 Eggert Stockfleth Use of a polyphenol for the treatment of actinic keratosis
FR2865911B1 (fr) 2004-02-06 2008-01-25 Oreal Dispositif de conditionnement et d'application comportant un organe d'essorage
US8075910B2 (en) * 2004-05-20 2011-12-13 Pbm Pharmaceuticals, Inc. Oral compositions comprising edible oils and vitamins and/or minerals and methods for making oral compositions
US20070059350A1 (en) * 2004-12-13 2007-03-15 Kennedy John P Agents for controlling biological fluids and methods of use thereof
US20060127437A1 (en) * 2004-12-13 2006-06-15 Misty Anderson Kennedy Semisolid system and combination semisolid, multiparticulate system for sealing tissues and/or controlling biological fluids
US8535709B2 (en) * 2004-12-13 2013-09-17 Southeastern Medical Technologies, Llc Agents for controlling biological fluids and methods of use thereof
US7125954B2 (en) * 2005-01-27 2006-10-24 General Electric Company Method for producing polyether polymers
GB201118198D0 (en) 2011-10-21 2011-12-07 Jagotec Ag Improvements in or relating to organic compounds
GB201118193D0 (en) 2011-10-21 2011-12-07 Jagotec Ag Improvements in or relating to oranic compounds
US9530532B2 (en) 2014-08-22 2016-12-27 Abb Schweiz Ag Hybrid conductor with circumferential conducting layers

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL129082C (de) * 1960-11-04
DK116528A (de) * 1966-09-30
DE2249552A1 (de) * 1971-10-12 1973-05-30 Inchema S A Verfahren zur inkapsulation von insbesondere wasserloeslichen verbindungen
US4371736A (en) * 1981-03-27 1983-02-01 E. I. Du Pont De Nemours And Company Herbicidal pyridinyloxy(pyrimidinyloxy)benzenes
WO1983000294A1 (en) * 1981-07-23 1983-02-03 Little Inc A Micellular drug delivery system
WO1984000906A1 (en) * 1982-08-30 1984-03-15 Labtest Equipment Company S E Nebulizer
US4622219A (en) * 1983-06-17 1986-11-11 Haynes Duncan H Method of inducing local anesthesia using microdroplets of a general anesthetic

Also Published As

Publication number Publication date
FI92647B (fi) 1994-09-15
FI871958A (fi) 1987-05-04
US4931284A (en) 1990-06-05
SE462894B (sv) 1990-09-17
DK327887A (da) 1987-06-26
ES2013724B3 (es) 1990-06-01
FI92647C (fi) 1994-12-27
KR940000230B1 (ko) 1994-01-12
FI871958A0 (fi) 1987-05-04
SE8505086D0 (sv) 1985-10-28
DK175157B1 (da) 2004-06-21
ZA867288B (en) 1987-05-27
SE8505086L (sv) 1987-04-29
IN165089B (de) 1989-08-12
EP0224457B1 (de) 1990-02-07
EP0224457A1 (de) 1987-06-03
CA1286928C (en) 1991-07-30
KR870700346A (ko) 1987-12-28
DK327887D0 (da) 1987-06-26
JPS63501150A (ja) 1988-04-28
AU6526586A (en) 1987-05-19
WO1987002582A1 (en) 1987-05-07
AU586513B2 (en) 1989-07-13
NZ217929A (en) 1989-04-26
ATE50158T1 (de) 1990-02-15
GR3000410T3 (en) 1991-06-28
PH21729A (en) 1988-02-10
IL80125A (en) 1990-07-26
IL80125A0 (en) 1986-12-31

Similar Documents

Publication Publication Date Title
DE3668792D1 (de) Mikrokapseln.
EP0336662A3 (de) Mikroverkapselung von Fischöl
IE811298L (en) Magnetically-localizable biodegradable lipid microspheres
KR910000655B1 (ko) 신규 형태의 연질캡슐 제조방법
EP0165352A3 (de) Durchsichtige mizellare Lösungen fettlöslicher essentieller Nahrungsmittel
SE8602931L (sv) Komposition med reglerad frigoring
KR840005024A (ko) 제약혼합물제제 및 그 제조방법
JP4109804B2 (ja) 香味油含有マイクロカプセルの製造方法
ES544649A0 (es) Procedimiento para la preparacion de etofibrato o compuestossimilares que contienen microgranulos de liberacion constan-te
EP0212875A3 (de) Arzneimittel, sowie Verfahren zu deren Herstellung
JPS5665820A (en) Hard capsule with high content of tocopherol nicotinate
JPH01186815A (ja) 軟カプセル剤およびその製造法
GB2303791A (en) Method of preparing a predetermined active agent stock solution for liposomal microencapsulation of active agents for agricultural uses
JPS55105615A (en) Microcapsule comprising hydrophobic medical substance and its preparation
FR2438481A1 (fr) Complexe lipoproteique normalisant l'efficacite de la vitamine e et des antioxydants de synthese
JPS6423860A (en) Soft capsule
IT8005116A0 (it) Procedimento per la preparazione di microcapsule.
JPS55153717A (en) Preparation of ubidecarenone soft capsule
JPS55139470A (en) Multicolored heat-sensitive recording material
JPS57131717A (en) Solid preparation containing ubidecarenone
NO176825B (no) Fremgangsmåte for fremstilling av mikrokapsler omfattende lipidkrystaller

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: JAGOTEC AG, MUTTENZ, CH